The Receptive–Expressive Emergent Language Test–Third Edition (REEL–3)
The Receptive–Expressive Emergent Language Test–Third Edition (REEL–3) is designed to help speech–language pathologists and other early childhood specialists identify infants and toddlers who have language impairments or who have other disabilities that affect language development, by determining the effect of physical and/or environmental risks on early speech and language development.
The REEL–3 uses the behavioral observations of parents or guardians to identify major language problems in youngsters up to 3 years of age. This instrument is a norm–reference tool, especially useful as an assessment and planning instrument in Early Childhood Intervention programs. Comprised of two core subtests, Receptive Language and Expressive Language, and a new supplementary subtest – Inventory of Vocabulary Words. Results, after a 20 minute testing time, are obtained from a caregiver interview with concomitant standard scores, age equivalents and percentile rankings.
The REEL–3 can be used for the following purposes:
Screening infants and toddlers for emergent language–learning problems
- Screening older preschoolers in whom delays are expected
- Obtaining a description of a child's present language environment
- Aiding clinical diagnosis
- Setting intervention goals
- Measuring delays in emergent speech and language development in infants with congenital anomalies and medically related handicaps
Sign up now!
APPROVED BY THE ILLINOIS EARLY INTERVENTION TRAINING PROGRAM FOR EARLY INTERVENTION CREDENTIAL CREDIT for 3.0 Hours
Disclosure: David C Saidoff, has the following relevant financial relationships to disclose: he receives monetary compensation for the preparation of this course, in addition to a percentage of company sales, and has the following relevant non-financial relationships to disclose: EITTOC Board of Directors: volunteer member. Kristen O’Leary, SLP, has the following relevant financial relationships to disclose: she receives monetary compensation for the preparation of this course, in addition to a percentage of company sales, and has the following relevant non-financial relationships to disclose: EITTOC Board of Directors: volunteer member. Declaration: Approval of this course does not necessarily imply that any of the governing bodies (e.g., West Virginian Board of Physical Therapy, or other such governmental or NGO’s supports the views of the presenter or sponsor. Information provided should be used within the scope of practice. No relevant financial or non-financial relationships exists between EITTOC or the products discussed any course; no such relationship or endorsement exists for any products mentioned in any courses sponsored by EITTOC, or in any of the items (such as specific AED or Epinephrine injection product) or any testing instrument used to evaluate children; the above course is specific to said-topic, and may not be extrapolated to any other course or topic outside the scope of this course. Course instructor(s) have no other financial or non-financial remuneration - whether prior to or following course delivery; the above advertisement is made available to all physical therapy (and other) licensee on a non-discriminatory basis. Ascend has approved this course and may be contacted about any concerns. Information provided should be used within scope of practice.